WATCH TV LIVE

NEWSMAX TV HEALTH MONEY WORLD
Tags: amgen | chemocentryx

Amgen to Buy ChemoCentryx in $3.7 Billion Deal

Amgen to Buy ChemoCentryx in $3.7 Billion Deal
(AP)

Thursday, 04 August 2022 08:05 AM EDT

Amgen Inc. said on Thursday it would buy ChemoCentryx Inc in a deal valued at $3.7 billion including debt to gain access to the company's blood disorder drug.

© 2026 Thomson/Reuters. All rights reserved.


Click Here to comment on this article
Share
StreetTalk
Amgen Inc. said on Thursday it would buy ChemoCentryx Inc in a deal valued at $3.7 billion including debt to gain access to the company's blood disorder drug.
amgen, chemocentryx
28
2022-05-04
Thursday, 04 August 2022 08:05 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved